ATHA
Price
$0.43
Change
+$0.01 (+2.38%)
Updated
Jul 11 closing price
Capitalization
16.98M
37 days until earnings call
EDIT
Price
$2.88
Change
-$0.18 (-5.88%)
Updated
Jul 11 closing price
Capitalization
241.09M
18 days until earnings call
Interact to see
Advertisement

ATHA vs EDIT

Header iconATHA vs EDIT Comparison
Open Charts ATHA vs EDITBanner chart's image
Athira Pharma
Price$0.43
Change+$0.01 (+2.38%)
Volume$270.83K
Capitalization16.98M
Editas Medicine
Price$2.88
Change-$0.18 (-5.88%)
Volume$2.25M
Capitalization241.09M
ATHA vs EDIT Comparison Chart in %
Loading...
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHA vs. EDIT commentary
Jul 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a StrongBuy and EDIT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 12, 2025
Stock price -- (ATHA: $0.42 vs. EDIT: $2.88)
Brand notoriety: ATHA and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 70% vs. EDIT: 94%
Market capitalization -- ATHA: $16.98M vs. EDIT: $241.09M
ATHA [@Biotechnology] is valued at $16.98M. EDIT’s [@Biotechnology] market capitalization is $241.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 1 FA rating(s) are green whileEDIT’s FA Score has 0 green FA rating(s).

  • ATHA’s FA Score: 1 green, 4 red.
  • EDIT’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATHA and EDIT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 4 TA indicator(s) are bullish while EDIT’s TA Score has 3 bullish TA indicator(s).

  • ATHA’s TA Score: 4 bullish, 4 bearish.
  • EDIT’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both ATHA and EDIT are a good buy in the short-term.

Price Growth

ATHA (@Biotechnology) experienced а +23.82% price change this week, while EDIT (@Biotechnology) price change was +12.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.52%. For the same industry, the average monthly price growth was +16.95%, and the average quarterly price growth was +21.18%.

Reported Earning Dates

ATHA is expected to report earnings on Aug 18, 2025.

EDIT is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+9.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($241M) has a higher market cap than ATHA($17M). EDIT YTD gains are higher at: 126.772 vs. ATHA (-25.891). ATHA has higher annual earnings (EBITDA): -77.65M vs. EDIT (-244.52M). EDIT has more cash in the bank: 221M vs. ATHA (36.7M). ATHA has less debt than EDIT: ATHA (1.12M) vs EDIT (31.1M). EDIT has higher revenues than ATHA: EDIT (35.8M) vs ATHA (0).
ATHAEDITATHA / EDIT
Capitalization17M241M7%
EBITDA-77.65M-244.52M32%
Gain YTD-25.891126.772-20%
P/E RatioN/AN/A-
Revenue035.8M-
Total Cash36.7M221M17%
Total Debt1.12M31.1M4%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATHAEDIT
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 15 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BREA6.570.44
+7.10%
Brera Holdings PLC
INTT7.680.17
+2.26%
inTEST Corp
ZBH93.79-1.36
-1.43%
Zimmer Biomet Holdings
SRAD28.57-0.60
-2.06%
Sportradar Group AG
THRY12.76-0.54
-4.06%
Thryv Holdings

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with OGEN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then OGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
+3.28%
OGEN - ATHA
38%
Loosely correlated
-2.74%
ALNY - ATHA
35%
Loosely correlated
-1.85%
PCVX - ATHA
33%
Poorly correlated
+0.42%
MNKD - ATHA
32%
Poorly correlated
-0.79%
SNGX - ATHA
31%
Poorly correlated
N/A
More

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with CRSP. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-5.88%
CRSP - EDIT
55%
Loosely correlated
-3.73%
AXON - EDIT
52%
Loosely correlated
-0.46%
VCYT - EDIT
49%
Loosely correlated
-1.60%
PRME - EDIT
49%
Loosely correlated
-7.25%
NTLA - EDIT
48%
Loosely correlated
-5.14%
More